In this file photo from Tuesday, Jan. 27, 2015, a BurgerFi restaurant employee prepares to add cheese to a veggie burger as she grills an order at the Aventura, Fla., restaurant. (AP Photo/Wilfredo Lee)
Plant-based products that do not contain meat can continue to be labeled “sausages” or “burgers,” European lawmakers said Friday, when they rejected a proposal back by the meat industry to ban the terms.
In votes on issues relating to agricultural products, the European Parliament said that so-called veggie burgers, soy steaks and vegan sausages can continue to be sold as such in restaurants and shops across the union.
Europe’s largest farmers' association, Copa-Cogeca, had supported a ban, arguing that labeling vegetarian substitutes with designations bringing meat to mind was misleading for consumers.
On the opposite side of the debate, a group of 13 organizations including Greenpeace and WWF urged lawmakers to reject the proposed amendments, arguing that a ban would have not only exposed the EU “to ridicule," but also damaged its environmental credibility.
They said promoting a shift toward more plant-based diet is in line with the EU Commission's ambition to tackle global warming. Losing the ability to use the terms steak or sausage might make those plant-based products more obscure for consumers.
After the vote, the European Consumer Organization, an umbrella group bringing together consumers' associations, praised the MEPs for their “common sense."
“Consumers are in no way confused by a soy steak or chickpea-based sausage, so long as it is clearly labeled as vegetarian or vegan," the group said in a statement. “Terms such as ‘burger’ or ‘steak’ on plant-based items simply make it much easier for consumers to know how to integrate these products within a meal."
Together with Greenpeace, the group regretted that lawmakers accepted further restrictions on the naming of alternative products containing no dairy. Terms like ‘almond milk’ and ‘soy yogurt’ are already banned in Europe after the bloc's top court ruled in 2017 that purely plant-based products can't be marketed using terms such as milk, butter or cheese, which are reserved for animal products.
Stocks closed lower Thursday amid continued volatility. The S&P 500 was down 10% from its record high, the Dow was down 7%, and the Nasdaq was 4% away from bear market territory as it closed 16% below its record high. Investors are still processing this week's Federal Reserve announcement about a potential first rate hike in March. Chris Gaffney, President of World Markets at TIAA Bank, joins Cheddar News' Closing Bell to discuss today's close, the Fed's announcement, predictions about interest rate hikes, and more.
Low-code app development platform Crowdbotics raised $22 million in a Series A funding round led by Jackson Square Ventures. Crowdbotics has helped more than 14,000 customers launch apps without having to learn how to code. The company can offer a team of expert developers to help companies launch custom apps, or provide the means for companies to develop apps themselves. Crowdbotics CEO Anand Kulkarni joined Cheddar News' Closing Bell to discuss.
Comcast announced that the company has beaten its projected earnings for Q4. However, the telecommunications giant fell short of its predictions for customer growth.
Kim Kardashian’s shapewear brand Skims has doubled its valuation to $3.2 billion. Investors have taken a bet on the success of this brand in the form of fresh funds for the two-year-old company.
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
